Physician profile
Sofia Emily Vasquez
NPI 1285791350
$11,456.35
in general payments reported to CMS, 2019-2025
39 companies · $2,183 in 2025
The $2,183 reported for 2025 was more than what 78% of Endocrinology, Diabetes & Metabolism providers received nationally (typical 2025 total: $506).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,257 · 2020: $2,509 · 2021: $1,983 · 2022: $1,564 · 2023: $1,172 · 2024: $790 · 2025: $2,183.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,101 · Education: $42.50.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,101.45 |
| Education | $42.50 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $3,143.33 | 2019-2025 | Wegovy, Ozempic, Rybelsus |
| Astrazeneca Pharmaceuticals Lp | $1,024.46 | 2019-2025 | Farxiga, Lokelma |
| Medtronic, INC. | $960.56 | 2021-2025 | Minimed 780g, Minimed 770g |
| Insulet Corporation | $835.99 | 2019-2025 | Omnipod |
| Mannkind Corporation | $781.75 | 2020-2025 | Afrezza |
| Dexcom, INC. | $727.20 | 2021-2025 | Dexcom G6 Transmitter, Dexcom G7 Gss (161) |
| Sanofi-Aventis U.S. LLC | $431.24 | 2019-2025 | |
| Amgen INC. | $322.36 | 2019-2025 | Tepezza, Repatha |
| Becton, Dickinson and Company | $314.51 | 2019-2022 | |
| Amneal Pharmaceuticals LLC | $268.78 | 2021-2025 | Unithroid |
| Tandem Diabetes Care, INC. | $258.15 | 2023-2025 | T:Slim X2 Insulin Pump With Control-Iq |
| Corcept Therapeutics | $256.67 | 2021-2025 | Korlym |
| Abbott Laboratories | $246.45 | 2019-2025 | Freestyle Libre 3 |
| Abbvie INC. | $240.61 | 2019-2025 | Synthroid |
| Medtronic Minimed, INC. | $170.74 | 2019-2020 |
Show all 39 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sofia Vasquez listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.